Chicago Partners Investment Group LLC Geron Corp Transaction History

Chicago Partners Investment Group LLC

$2.81 Billion
Q3 2024

A detailed history of Chicago Partners Investment Group LLC transactions in Geron Corp stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 24,815 shares of GERN stock, worth $100,997. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,815

Previous 23,101 7.42%

Holding current value

$100,997

Previous $97,000 15.46%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$4.17 - $4.99 $7,147 - $8,552	1,714 Added 7.42%	24,815 $112,000
Q2 2024 Jul 31, 2024	SELL	$3.1 - $5.09 $35,966 - $59,054	-11,602 Reduced 33.43%	23,101 $97,000
Q1 2024 Apr 25, 2024	BUY	$1.75 - $3.44 $1,023 - $2,012	585 Added 1.71%	34,703 $114,000
Q4 2023 Feb 23, 2024	BUY	$1.74 - $2.31 $7,398 - $9,822	4,252 Added 14.24%	34,118 $71,000
Q3 2023 Oct 26, 2023	BUY	$2.11 - $3.28 $18,055 - $28,066	8,557 Added 40.16%	29,866 $63,000
Q2 2023 Aug 07, 2023	BUY	$1.97 - $3.69 $18,246 - $34,176	9,262 Added 76.88%	21,309 $68,000
Q1 2023 Apr 26, 2023	SELL	$2.14 - $3.4 $48,995 - $77,843	-22,895 Reduced 65.52%	12,047 $26,000
Q4 2022 Feb 09, 2023	BUY	$2.03 - $2.42 $9,569 - $11,407	4,714 Added 15.59%	34,942 $84,000
Q3 2022 Nov 09, 2022	BUY	$1.67 - $2.94 $8,243 - $14,511	4,936 Added 19.52%	30,228 $63,000
Q2 2022 Aug 04, 2022	BUY	$1.19 - $1.65 $1,075 - $1,491	904 Added 3.71%	25,292 $48,000
Q1 2022 May 20, 2022	SELL	$0.99 - $1.6 $15,063 - $24,345	-15,216 Reduced 38.42%	24,388 $32,000
Q4 2021 Feb 15, 2022	SELL	$1.22 - $1.72 $7,790 - $10,983	-6,386 Reduced 13.89%	39,604 $40,000
Q3 2021 Nov 12, 2021	SELL	$1.2 - $1.5 $6,553 - $8,191	-5,461 Reduced 10.61%	45,990 $63,000
Q2 2021 Aug 02, 2021	BUY	$1.25 - $1.83 $3,668 - $5,371	2,935 Added 6.05%	51,451 $66,000
Q1 2021 Apr 28, 2021	BUY	$1.52 - $2.1 $8,299 - $11,466	5,460 Added 12.68%	48,516 $73,000
Q4 2020 Jan 27, 2021	BUY	$1.55 - $2.05 $25,460 - $33,673	16,426 Added 61.68%	43,056 $74,000
Q3 2020 Nov 06, 2020	BUY	$1.59 - $2.19 $42,341 - $58,319	26,630 New	26,630 $48,000
Q4 2018 Jan 11, 2019	SELL	$0.98 - $1.85 $392 - $740	-400 Closed	0 $0
Q3 2017 Nov 22, 2017	BUY	$1.99 - $2.65 $796 - $1,060	400	400 $0

Others Institutions Holding GERN

# of Institutions

275

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.54B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Partners Investment Group LLC with notifications on news.

Account

Chicago Partners Investment Group LLC Geron Corp Transaction History